BlackRock Fund Advisors’s Atara Biotherapeutics ATRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2016
Q4
$15.8M Buy
44,460
+5,417
+14% +$1.92M ﹤0.01% 2312
2016
Q3
$20.9M Buy
39,043
+2,486
+7% +$1.33M ﹤0.01% 2047
2016
Q2
$20.6M Buy
36,557
+5,730
+19% +$3.22M ﹤0.01% 2011
2016
Q1
$14.7M Buy
30,827
+883
+3% +$420K ﹤0.01% 2153
2015
Q4
$19.8M Buy
29,944
+13,874
+86% +$9.16M ﹤0.01% 2048
2015
Q3
$12.6M Buy
16,070
+2,222
+16% +$1.75M ﹤0.01% 2266
2015
Q2
$18.3M Buy
13,848
+6,099
+79% +$8.04M ﹤0.01% 2170
2015
Q1
$8.05M Buy
7,749
+1,432
+23% +$1.49M ﹤0.01% 2570
2014
Q4
$4.22M Buy
+6,317
New +$4.22M ﹤0.01% 2965